The U.S. Food and Drug Administration (FDA) currently limits pharmaceutical companies’ ability to promote products to their approved indications, however, after recent legal setbacks, the FDA decided to undergo a review of their policies. Are looser off-label promotion restrictions needed? Find out more here. (Source: Michael Mezher, RAPS, 11/14/16)
You are here: / / Are Looser Off-Label Promotion Restrictions Needed?